![\"Ivermection](\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2025\/10\/Ivermection_Reduces_Tumours.jpg\")
<\/p>\n<\/p>\n
Another ivermectin study is out, and like the long list of similar studies lately, it shows more cancer treatment potential. This one was published in July in ACS Biomaterials Science, titled, \u201cIntranasal Delivery of Ivermectin Nanosystems as an Antitumor Agent: Focusing on Glioma Suppression.\u201d<\/p>\n
In short, the study found low-dose ivermectin shrank brain tumors by a whopping 70% in rats. The treated rodents also had less dead tissue, less swelling, and fewer new blood vessels forming, which means the remaining tumors were less invasive and less aggressive.<\/p>\n
The ivermectin was delivered using a nasal spray in a very fine (nanoscale) form, since oral ivermectin can\u2019t cross the blood-brain barrier. The rats that got the treatment showed no negative side effects.<\/p>\n
The serendipitous discovery of ivermectin is one of the most remarkable stories in medical science. In the 1970s, Japanese microbiologist Satoshi Omura set out to find new microorganisms that might produce useful medicines. He collected hundreds of soil samples from around Japan, including one from a golf course in Kawana, south of Tokyo.<\/p>\n
In one of his golf-course soil samples, Omura\u2019s team isolated a previously unknown bacterium that produced compounds found to be extraordinarily effective at killing parasitic worms. He sent it to a U.S. lab at Merck, which developed ivermectin: a safer and even more potent chemical derivative of the bacterial compound.<\/p>\n
As you know, in 2015, Omura and Merck researcher Bill Campbell jointly received the Nobel Prize in Medicine for a cheap dirt drug that has saved millions from disease and blindness. If ivermectin\u2019s cancer-fighting abilities bear out \u2014and the studies and anecdotes keep mounting up\u2014 it will become the single most beneficial accidental discovery in human history.<\/p>\n
Here\u2019s a question to ponder: would ivermectin have broken out of the pharma wilderness absent its high-profile role during the pandemic as a cultural and political flashpoint? Without this extraordinary exposure, efforts to study ivermectin as a cancer agent would almost certainly have remained niche\u2014 buried in the literature amid hundreds of other \u201cdrug repurposing\u201d efforts, lacking funding, conference time, or media coverage.<\/p>\n
Ivermectin may wind up being the greatest covid miracle of all.<\/p>\n